Zhongsheng Peng

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 6

Top Topics

Epithelial Mesenchymal Transition

Gold Nanoparticles

Top Venues

Molecular cancer therapeutics

Therapeutic advances in medical oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for correlations between metabolites in patients receiving immunotherapy for metastatic or recurrent NSCLC: an exploratory study based on two cohorts. Molecular cancer therapeutics (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)
Kaibo Ding, Zhongsheng Peng, Yanjun Xu
Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers. Therapeutic advances in medical oncology 16 (2024)
Kaibo Ding, Zhongsheng Peng, Yanjun Xu
Role of immunotherapy in pulmonary sarcomatoid carcinoma: review of current approaches and related biomarkers. Therapeutic advances in medical oncology 16 (2024)
Yanjun Xu, Kaibo Ding, Zhongsheng Peng, Ling Ding, Hui Li, Yun Fan
Evaluating for Correlations between Specific Metabolites in Patients Receiving First-Line or Second-Line Immunotherapy for Metastatic or Recurrent NSCLC: An Exploratory Study Based on Two Cohorts. Molecular cancer therapeutics 23 (5) (2024)